Literature DB >> 23754489

Acidosis inhibits mineralization in human osteoblasts.

Shoko Takeuchi1, Koji Hirukawa, Akifumi Togari.   

Abstract

Osteoblasts and osteoclasts maintain bone volume. Acidosis affects the function of these cells including mineral metabolism. We examined the effect of acidosis on the expression of transcription factors and mineralization in human osteoblasts in vitro. Human osteoblasts (SaM-1 cells) derived from the ulnar periosteum were cultured with α-MEM containing 50 μg/ml ascorbic acid and 5 mM β-glycerophosphate (calcifying medium). Acidosis was induced by incubating the SaM-1 cells in 10 % CO₂ (pH approximately 7.0). Mineralization, which was augmented by the calcifying medium, was completely inhibited by acidosis. Acidosis depressed c-Jun mRNA and increased osteoprotegerin (OPG) production in a time-dependent manner. Depressing c-Jun mRNA expression using siRNA increased OPG production and inhibited mineralization. In addition, depressing OPG mRNA expression with siRNA enhanced mineralization in a dose-dependent manner. Acidosis or the OPG protein strongly inhibited mineralization in osteoblasts from neonatal mice. The present study was the first to demonstrate that acidosis inhibited mineralization, depressed c-Jun mRNA expression, and induced OPG production in human osteoblasts. These results suggest that OPG is involved in mineralization via c-Jun in human osteoblasts.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23754489     DOI: 10.1007/s00223-013-9746-2

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  9 in total

Review 1.  The role of fetuin-A in mineral trafficking and deposition.

Authors:  Michael M X Cai; Edward R Smith; Stephen G Holt
Journal:  Bonekey Rep       Date:  2015-05-06

2.  Obstructive Sleep Apnea and Risk for Incident Vertebral and Hip Fracture in Women.

Authors:  Tianyi Huang; Shelley S Tworoger; Susan Redline; Gary C Curhan; Julie M Paik
Journal:  J Bone Miner Res       Date:  2020-09-09       Impact factor: 6.741

3.  Evidence that activation of ASIC1a by acidosis increases osteoclast migration and adhesion by modulating integrin/Pyk2/Src signaling pathway.

Authors:  X Li; J-X Ye; M-H Xu; M-D Zhao; F-L Yuan
Journal:  Osteoporos Int       Date:  2017-05-01       Impact factor: 4.507

Review 4.  Effects of acid on bone.

Authors:  David A Bushinsky; Nancy S Krieger
Journal:  Kidney Int       Date:  2022-03-26       Impact factor: 18.998

5.  Acetazolamide sensitive tissue calcification and aging of klotho-hypomorphic mice.

Authors:  Christina B Leibrock; Ioana Alesutan; Jakob Voelkl; Diana Michael; Tatsiana Castor; Ursula Kohlhofer; Leticia Quintanilla-Martinez; Laura Kübler; Julia G Mannheim; Bernd J Pichler; Kevin P Rosenblatt; Makoto Kuro-o; Florian Lang
Journal:  J Mol Med (Berl)       Date:  2015-08-27       Impact factor: 4.599

6.  Acidosis is a key regulator of osteoblast ecto-nucleotidase pyrophosphatase/phosphodiesterase 1 (NPP1) expression and activity.

Authors:  Isabel R Orriss; Michelle L Key; Mark O R Hajjawi; José L Millán; Timothy R Arnett
Journal:  J Cell Physiol       Date:  2015-12       Impact factor: 6.384

Review 7.  Molecular actions of ovarian cancer G protein-coupled receptor 1 caused by extracellular acidification in bone.

Authors:  Feng-Lai Yuan; Ming-Dong Zhao; Li-Bo Jiang; Hui-Ren Wang; Lu Cao; Xiao-Gang Zhou; Xi-Lei Li; Jian Dong
Journal:  Int J Mol Sci       Date:  2014-12-03       Impact factor: 5.923

8.  Potassium citrate prevents increased osteoclastogenesis resulting from acidic conditions: Implication for the treatment of postmenopausal bone loss.

Authors:  Donatella Granchi; Elena Torreggiani; Annamaria Massa; Renata Caudarella; Gemma Di Pompo; Nicola Baldini
Journal:  PLoS One       Date:  2017-07-17       Impact factor: 3.240

Review 9.  Life-course approach to nutrition.

Authors:  P J Mitchell; C Cooper; B Dawson-Hughes; C M Gordon; R Rizzoli
Journal:  Osteoporos Int       Date:  2015-09-28       Impact factor: 4.507

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.